Effects of Chronic Masitinib Treatment in APPswe/PSEN1dE9 Transgenic Mice Modeling Alzheimer’s Disease-Reference-Cited by-同舟云学术

Effects of Chronic Masitinib Treatment in APPswe/PSEN1dE9 Transgenic Mice Modeling Alzheimer’s Disease

Published:2020-08-18 Issue:4 Volume:76 Page:1339-1345
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Li Tengfei¹,Martin Elodie¹,Abada Yah-se¹,Boucher Céline¹,Cès Aurélia¹,Youssef Ihsen¹,Fenaux Grégory²,Forand Yona²,Legrand Annaelle²,Nachiket Nadkarni³⁴,Dhenain Marc³⁴,Hermine Olivier⁵,Dubreuil Patrice²,Delarasse Cécile¹⁶,Delatour Benoît¹

Affiliation:

1. ICM Institut du Cerveau et de la Moelle épinière, CNRS UMR7225, INSERM U1127, Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France

2. CRCM, [Signaling, Hematopoiesis and Mechanism of Oncogenesis, Equipe Labellisée Ligue Contre le Cancer], Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Univ, UM105; CNRS, UMR7258, Marseille, France

3. Centre National de la Recherche Scientifique (CNRS), Université Paris-Sud, Université Paris-Saclay UMR 9199, Neurodegenerative Diseases Laboratory, Fontenay-aux-Roses, France

4. Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), Direction de la Recherche Fondamentale (DRF), Institut François Jacob, MIRCen, Fontenay-aux-Roses, France

5. Department of Hematology, INSERM UMR1163 and CNRS URL 8254, Imagine Institute, Paris Descartes University-Sorbonne Paris Cité, Necker Children’s Hospital, APHP, Paris, France

6. Sorbonne Université, Inserm, CNRS, Institut de la Vision, 17, Paris, France

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference19 articles.

1. Lessons learned from Alzheimer disease: Clinical trials with negative outcomes;Cummings;Clin Transl Sci,2017

2. Masitinib as an adjunct therapy for mild-to-moderate Alzheimer’s disease: A randomised, placebo-controlled phase 2 trial;Piette;Alzheimers Res Ther,2011

3. Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT;Dubreuil;PLoS One,2009

4. Mast cells in neuroinflammation and brain disorders;Hendriksen;Neurosci Biobehav Rev,2017

5. Mast cells in neurodegenerative disease;Jones;Front Cell Neurosci,2019

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on immunotherapy in neurodegenerative diseases;Brain Research;2024-12

2. Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes;Frontiers in Dementia;2024-08-16

3. c-KIT inhibitors reduce pathology and improve behavior in the Tg(SwDI) model of Alzheimer’s disease;Life Science Alliance;2024-07-15

4. Multi-target drugs for Alzheimer's disease;Trends in Pharmacological Sciences;2024-07

5. Neuroimmune Dysfunction in Alzheimer’s Disease and Other Forms of Dementia;Chemical and Pharmaceutical Bulletin;2024-07-01